Transient Ischemic Attack Archives

Impact of COVID-19 on Stroke, and TIA Admission Rates, and Prognosis

By

Amit Akirov, MD

August 26, 2020

The admission rates of ischemic stroke and TIA were lower during the first weeks of the 2020 COVID-19 lockdown compared with those of 2017-2019.

Stroke

Anticoagulant vs Antiplatelet Therapy in Recurrent Ischemic Stroke Risk

By

Brandon May

August 13, 2020

Study authors compared the safety and efficacy of oral anticoagulants vs antiplatelets in patients with stroke and supracardiac atherosclerosis.

Stroke

Ticagrelor-Aspirin Beneficial for Mild-to-Moderate Stroke, TIA

July 22, 2020

Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or TIA.

Stroke

Recommendations for Management of Ischemic Stroke in Adults With COVID-19

By

Amit Akirov, MD

June 1, 2020

A panel prepared a comprehensive set of practice implications for clinicians caring for adults with acute ischemic stroke with confirmed or suspected of having COVID-19.

Vascular Neurology

Predictors of Atrial Fibrillation in Patients With Transient Ischemic Attack

By

Amit Akirov, MD

March 31, 2020

Patients with transient ischemic attack with high brain natriuretic peptide values are more likely to have atrial fibrillation.

Stroke

Higher Combined oxLDL and LDL Levels Found to Be Associated With Recurrent Stroke

By

Neurology Advisor Contributing Writer

March 26, 2020 11:20 am

The combination of higher serum oxLDL and LDL levels was found to be associated with an increased risk for recurrent stroke and poor functional outcomes in patients who have had minor stroke or are at high risk for TIAs.

AtrialFibrillationWithHeart_MI_01AFTFMK_cropped

Stroke

Vitamin K Antagonist Cessation and Stroke/TIA Risk in Newly Diagnosed Atrial Fibrillation

By

Gary Rothbard, MD, MS

March 6, 2020

Discontinuation of vitamin K antagonist oral anticoagulant therapy was associated with an elevated risk for stroke or transient ischemic attack in patients newly diagnosed with nonvalvular atrial fibrillation.

Stroke

Risk Factors Are Frequently Inadequately Treated in Patients With Stroke or TIA

By

Amit Akirov, MD

January 6, 2020

In patients with ischemic stroke and TIA there is a significant gap between cerebrovascular risk factors control and real-world stroke prevention.

Stroke

Serum Biomarkers Do Not Aid in Diagnosis of Transient Ischemic Attacks

By

Rita Aghjayan

January 3, 2020

Blood biomarkers currently do not have diagnostic value for patients with suspected TIA, indicating that the sudden onset of symptoms and “onset in full intensity” are still the most valuable clinical predictors of TIA and minor stroke.

Stroke

AHA Finds Lower Target LDL Beneficial After Stroke and TIA

November 26, 2019

For patients with ischemic stroke or transient ischemic attack (TIA) with evidence of atherosclerosis, those with a target low-density lipoprotein (LDL) cholesterol level of less than 70 mg/dL have a lower risk for cardiovascular events.